Stock Events

Stock Events

Illumina 

$139.07
472
-$0.3-0.22% Tuesday 19:55

Statistics

Day High
142.41
Day Low
136.36
52W High
153.95
52W Low
74.53
Volume
1,236,280
Avg. Volume
-
Mkt Cap
21.26B
P/E Ratio
24.69
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12AugExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
0.91
1.06
1.2
1.35
Expected EPS
1.226417
Actual EPS
N/A

Financials

19.57%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
8.69BRevenue
1.7BNet Income

Analyst Ratings

137.75Average Price Target
The highest estimate is 170.00.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy
38%
Hold
38%
Sell
25%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ILMN. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pacific Biosciences of California
PACB
Mkt Cap496.78M
Pacific Biosciences offers long-read sequencing technologies that compete with Illumina's short-read sequencing platforms, providing an alternative in genomic sequencing.
Thermo Fisher Scientific
TMO
Mkt Cap174.37B
Thermo Fisher Scientific competes with Illumina in the life sciences and diagnostics market, offering a range of sequencing and genetic analysis products.
Bio-Rad Laboratories
BIO.B
Mkt Cap8.84B
Bio-Rad Laboratories provides a variety of research and clinical diagnostic products that compete with Illumina's offerings in genomic and molecular diagnostics.
Qiagen NV
QGEN
Mkt Cap7.06B
Qiagen competes with Illumina in the provision of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research.
Roche
RHHBY
Mkt Cap328.49B
Roche Holding AG competes through its acquisition of GenMark Diagnostics and a strong portfolio in diagnostics and genomic sequencing, challenging Illumina's market share.
Agenus
AGEN
Mkt Cap147.45M
Agilent Technologies offers a range of products for genomics and molecular biology that compete with Illumina's sequencing and array technologies.
Intellia Therapeutics
NTLA
Mkt Cap1.58B
Intellia Therapeutics is involved in CRISPR technology, which, while not a direct competitor in sequencing, competes in the broader genomics market where Illumina operates.
Editas Medicine
EDIT
Mkt Cap283.93M
Editas Medicine is focused on gene editing technology, representing a competitive force in the genomics industry by offering alternative approaches to genetic analysis and modification.
CRISPR Therapeutics
CRSP
Mkt Cap4.98B
CRISPR Therapeutics is engaged in gene-based medicine, indirectly competing with Illumina by advancing the application of genomics in therapeutic development.

About

There is no Profile data available for ILU.SG.
Show more...
CEO
Mr. Jacob Thaysen Ph.D.
Employees
8970
Country
United States
ISIN
US4523271090

Listings

MU
DE
ILU.MU
LSE
GB
0J8Z.LSE
STU
DE
ILU.STU
MI
IT
1ILMN.MI

0 Comments

Share your thoughts

FAQ

What is Illumina stock price today?▼
The current price of ILMN is $139.07 USD — it has decreased by -0.22% in the past 24 hours. Watch Illumina stock price performance more closely on the chart.
What is Illumina stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Illumina stocks are traded under the ticker ILMN.
Is Illumina stock price growing?▼
ILMN stock has risen by +15.54% compared to the previous week, the month change is a +8.87% rise, over the last year Illumina has showed a +86.6% increase.
What is Illumina market cap?▼
Today Illumina has the market capitalization of 21.26B
When is the next Illumina earnings date?▼
Illumina is going to release the next earnings report on August 12, 2026.
What were Illumina earnings last quarter?▼
ILMN earnings for the last quarter are 1.15 USD per share, whereas the estimation was 1.05 USD resulting in a +9.06% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Illumina revenue for the last year?▼
Illumina revenue for the last year amounts to 8.69B USD.
What is Illumina net income for the last year?▼
ILMN net income for the last year is 1.7B USD.
How many employees does Illumina have?▼
As of May 06, 2026, the company has 8,970 employees.
In which sector is Illumina located?▼
Illumina operates in the Health & Wellness sector.
When did Illumina complete a stock split?▼
The last stock split for Illumina was on September 23, 2008 with a ratio of 2:1.
Where is Illumina headquartered?▼
Illumina is headquartered in San Diego, United States.